Display Settings:

Format

Send to:

Choose Destination

    Blood. 2008 Feb 15;111(4):1774-80. Epub 2007 Nov 30.

    Monitoring the response and course of chronic myeloid leukemia in the modern era of BCR-ABL tyrosine kinase inhibitors: practical advice on the use and interpretation of monitoring methods.

    Kantarjian H, Schiffer C, Jones D, Cortes J.

    Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. hkantarj@mdanderson.org

    PMID: 18055868 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read